Critical care dialysis - A gordian knot (but is untying the right approach?)

Nephrology Dialysis Transplantation

Volumn 14, Issue 11, 1999, Pages 2590-2594

  Kanagasundaram, Nigel Suren ^a   Paganini, Emil Presley ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; OXYGEN; UREA;

ACUTE KIDNEY FAILURE; BIOCOMPATIBILITY; BLEEDING; CLEARANCE; CONTROLLED STUDY; DIALYSIS; DIALYSIS MEMBRANE; HEMODYNAMICS; HEMOFILTRATION; HUMAN; HYPOTENSION; INTENSIVE CARE; KIDNEY FAILURE; MORTALITY; NOTE; OXYGEN CONSUMPTION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SEPSIS; SURVIVAL; ULTRAFILTRATION;

EID: 0033281523     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.11.2590     Document Type: Note

References (46)

1. Dialysis is not dialysis is not dialysis! Acute dialysis is different and needs help!
2. NKF-DOQI clinical practice guidelines for hemodialysis adequacy
3. On the design and analysis of multicentre trials in acute renal failure
4. Control of dialysis by single-pool urea model: The National Co-operative Dialysis Study
5. Protein catabolic rate in patients with acute renal failure on continuous arteriovenous hemofiltration and total parenteral nutrition
6. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure
7. Extracorporeal therapy requirements for patients with acute renal failure
8. Urea kinetics during continuous hemofiltration
9. The evolution of acute renal failure, 1956-1988
10. The effect of acute renal failure on mortality: A cohort analysis
11. Predicting mortality in intensive care patients with acute renal failure treated with dialysis
12. Effect of the dialysis membrane in the treatment of patients with acute renal failure
13. Biocompatible membranes in acute renal failure: Prospective case-controlled study
14. Use of APACHE II classification to evaluate outcome and response to therapy in acute renal failure patients in a surgical intensive care unit
15. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care
16. Human albumin administration in critically ill patients: Systematic review of randomised controlled trials
17. Does continuous renal replacement therapy favourably influence the outcome of the patients?
18. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure
19. Continuous venovenous hemodialysis after cardiac surgery
20. Continuous versus intermittent forms of hemofiltration and/or dialysis in the management of acute renal failure in patients with defective cerebral autoregulation at risk of cerebral oedema
21. Continuous venovenous hemodiafiltration compared with conventional dialysis in critically ill patients with ARF
22. A comparison of conventional dialytic therapy and acute hemodiafiltration in the management of acute renal failure in the critically ill
23. Slow continuous ultrafiltration in hemodialysis resistant oliguric acute renal failure patients
24. Hemodynamic consequences of continuous arteriovenous hemofiltration
25. A randomised cross-over comparison of the hemodynamic response to intermittent hemodialysis and continuous hemofiltration in ICU patients with acute renal failure
26. Acute dialytic support for the critically ill: Intermittent hemodialysis versus continuous arteriovenous hemodiafiltration
27. Slow continuous hemofiltration and slow continuous ultrafiltration
28. Performance characteristics of contemporary hemodialysis and venovenous hemofiltration in acute renal failure
29. Does hemodialysis delay recovery from acute renal failure?
30. The effect of sodium and ultrafiltration modelling on plasma volume changes and haemodynamic stability in intensive care patients receiving haemodialysis for acute renal failure: A prospective, stratified, randomized, cross-over study
31. Establishing a dialysis therapy/patient outcome link in intensive care unit acute dialysis for patients with acute renal failure
32. Quantifying hemodialysis and peritoneal dialysis: Examination of the peak concentration hypothesis
33. Intermittent versus continuous treatment for acute renal failure: Where do we stand?
34. The peak concentration hypothesis: A urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis
35. Continuous renal replacement therapies in sepsis: Where are the data?
36. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates
37. A comparison of continuous arteriovenous hemofiltration and intermittent hemodialysis in acute renal failure patients in the intensive care unit
38. Continuous versus intermittent treatment: Clinical results in acute renal failure
39. Validity of four models for predicting outcome in critically ill acute renal failure patients
40. Comparison of SAPS, APACHE II and OSF in the evaluation of severe acute renal failure (ARF)
41. Survival of dialysis dependent acute renal failure (ARF) patients predicted by APACHE II (APII) score
42. Evaluation of severity scoring systems in ICUs-translation, conversion and definition ambiguities as a source of inter-observer variability in APACHE II, SAPS and OSF
43. A new approach to dialysis quantification: An adequacy index based on solute removal
44. The solute removal index: A unified basis for comparing disparate therapies
45. A randomized, stratified, dose equivalent comparison of continuous venovenous hemodialysis (CVVHD) vs intermittent hemodialysis (IHD) support in ICU acute renal failure patients (ARF)